.

ISSN 2063-5346
For urgent queries please contact : +918130348310

A Case-Control Study of the Role of Haematological Biomarkers in the Disease Monitoring of Diabetic COVID-19 Infected Patients

Main Article Content

Uma Satyanarayana Pamidi1,2, Palanisamy Selvaraj1, Santhi Naidu Kamatham3, Muddukrishnaiah Kotakonda4, Natesan Vijayakumar1, Natarajan Ashok Kumar1, Subramani Srinivasan1,5, Murali Raju1,5.
» doi: 10.48047/ecb/2023.12.10.055

Abstract

COVID-19 is an infectious disease caused by the SARSCoV-2 virus, triggering a worldwide sanitary emergency. COVID-19 has many clinical manifestations, ranging from asymptomatic infection to mild to severe pneumonia. The current study conducted blood parameters change in diabetic COVID-19-infected patients with treatment and without treatment. Biomarkers make them useful as important biomarkers to assess disease progression and categorise patients who may present with severe and fatal clinical conditions. The study was conducted on 1000 patients in a multi-facility hospital in Hyderabad to examine the biochemical parameters (CRP, NT-Pro-BNP, D-Dimer, Ferritin, Interleukin-6 (IL-6), Lactate dehydrogenase (LDH), Procalcitonin (PCT) and Troponin I) markers levels in diabetic COVID-19 patients with medication and without medication.

Article Details